These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3308491)

  • 1. Chronic treatment with antidepressants decreases the number of [3H]SCH 23390 binding sites in the rat striatum and limbic system.
    Klimek V; Nielsen M
    Eur J Pharmacol; 1987 Jul; 139(2):163-9. PubMed ID: 3308491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of chronic antidepressant treatment on dopamine-related [3H]SCH 23390 and [3H]spiperone binding in the rat striatum.
    Paetsch PR; Greenshaw AJ
    Cell Mol Neurobiol; 1992 Dec; 12(6):597-606. PubMed ID: 1490276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lateralization of neocortical dopamine receptors and dopamine level in normal Wistar rats.
    Nowak G
    Pol J Pharmacol Pharm; 1989; 41(2):133-7. PubMed ID: 2687822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum.
    Billard W; Ruperto V; Crosby G; Iorio LC; Barnett A
    Life Sci; 1984 Oct; 35(18):1885-93. PubMed ID: 6387355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressant drugs given repeatedly change the binding of the dopamine D2 receptor agonist, [3H]N-0437, to dopamine D2 receptors in the rat brain.
    Maj J; Dziedzicka-Wasylewska M; Rogoz R; Rogóz Z; Skuza G
    Eur J Pharmacol; 1996 May; 304(1-3):49-54. PubMed ID: 8813583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central dopaminergic transmission is selectively increased in the limbic system of rats chronically exposed to antidepressants.
    De Montis GM; Devoto P; Gessa GL; Meloni D; Porcella A; Saba P; Serra G; Tagliamonte A
    Eur J Pharmacol; 1990 May; 180(1):31-5. PubMed ID: 2163864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic imipramine reduces [3H]SCH 23390 binding and DA-sensitive adenylate cyclase in the limbic system.
    De Montis GM; Devoto P; Gessa GL; Meloni D; Porcella A; Saba P; Serra G; Tagliamonte A
    Eur J Pharmacol; 1989 Aug; 167(2):299-303. PubMed ID: 2687009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased 3H-spiperone binding sites in mesolimbic area related to methamphetamine-induced behavioral hypersensitivity.
    Akiyama K; Sato M; Otsuki S
    Biol Psychiatry; 1982 Feb; 17(2):223-31. PubMed ID: 7200378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of standard neuroleptic compounds on the binding of 3H-spiroperidol in the striatum and mesolimbic system of the rat in vitro.
    Howard JL; Large BT; Wedley S; Pullar IA
    Life Sci; 1978 Aug; 23(6):599-603. PubMed ID: 29198
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
    Thomas KL; Rose S; Jenner P; Marsden CD
    Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated administration of antidepressants enhances agonist affinity for mesolimbic D2-receptors.
    Klimek V; Maj J
    J Pharm Pharmacol; 1989 Aug; 41(8):555-8. PubMed ID: 2571700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective and stereospecific interactions of R-SK & F 38393 with [3H]piflutixol but not [3H]spiperone binding to striatal D1 and D2 dopamine receptors: comparisons with SCH 23390.
    O'Boyle KM; Waddington JL
    Eur J Pharmacol; 1984 Mar; 98(3-4):433-6. PubMed ID: 6144559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lasting changes in high affinity 3H-spiperone binding to the rat striatum and mesolimbic area after chronic methamphetamine administration: evaluation of dopaminergic and serotonergic receptor components.
    Akiyama K; Sato M; Kashihara K; Otsuki S
    Biol Psychiatry; 1982 Dec; 17(12):1389-402. PubMed ID: 7159638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of flunarizine with dopamine D2 and D1 receptors.
    Ambrosio C; Stefanini E
    Eur J Pharmacol; 1991 May; 197(2-3):221-3. PubMed ID: 1833208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of [3H]SCH 23390 to dopamine D-1 receptors in rat retina in vitro.
    Gredal O; Parkinson D; Nielsen M
    Eur J Pharmacol; 1987 Jun; 137(2-3):241-5. PubMed ID: 2886353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of [3H]SCH 23390 specific binding sites in anterior pituitary: dissociation from effects on prolactin secretion.
    Rovescalli AC; Brunello N; Monopoli A; Ongini E; Racagni G
    Eur J Pharmacol; 1987 Mar; 135(2):129-36. PubMed ID: 3556197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of 7-[3-(4-[2,3-dimethylphenyl]piperazinyl)-propoxy]-2(1H)-quinolinone binding in rat striatum: effects of lesions.
    Zhang X; Nakata Y; Kikuchi T; Segawa T
    Pharm Res; 1990 Mar; 7(3):280-2. PubMed ID: 1971105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding characteristics of the dopamine agonist/antagonist [3H]terguride (transdihydrolisuride) in the rat striatum.
    Valchár M; Vrsecká M; Krejcí I; Dlabac A
    Eur J Pharmacol; 1987 Apr; 136(1):97-101. PubMed ID: 3297739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of [3H]SCH 23390 binding sites in the rat adrenal gland.
    Zdilar D; Lacković Z
    J Pharm Pharmacol; 1989 Sep; 41(9):646-8. PubMed ID: 2573713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic D-amphetamine and phencyclidine: effects on dopamine agonist and antagonist binding sites in the extrapyramidal and mesolimbic systems.
    Robertson HA
    Brain Res; 1983 May; 267(1):179-82. PubMed ID: 6860944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.